The company, which manufactures intermediate chemicals and active pharmaceutical ingredients (API) commenced production in April 2019 with an investment of Rs 200 crore.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.